SEC Form 4 · accession 0001543077-15-000004
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey D Abbey
Officer — CEO · Director
Period of report
Dec 2, 2015
Accepted (ET)
Dec 3, 2015 · 3:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 2, 2015 | P | 1,000 | $3.8894 | A | 6,293 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,330 shares of Common Stock acquired pursuant to the 2014 Employee Stock Purchase Plan on March 5, 2015 and 1,383 shares of Common Stock acquired pursuant to the 2014 Employee Stock Purchase Plan on September 4, 2015.